Skip to main content
  • SMART Trial Analysis Confirms SEV’s Hemodynamic Superiority Over BEV in Aortic Stenosis Patients with Small Annuli

    A new analysis of the SMART trial suggests that self-expanding valves (SEVs) are hemodynamically superior to balloon-expandable valves (BEVs) in aortic stenosis patients with small aortic annuli undergoing transcatheter aortic valve replacement (TAVR).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details